Dissolving stent could revolutionize treatment for long heart blockages

NCT ID NCT07091682

First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times

Summary

This study tests a new type of heart stent made from magnesium that slowly dissolves over time. It is designed for people with long blockages in their heart arteries. The goal is to see if the stent is safe and works well at keeping arteries open for up to 12 months. About 100 participants with coronary artery disease will be enrolled.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROMES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Azienda Ospedaliera Universitaria Integrata Verona

    RECRUITING

    Verona, 37126, Italy

  • Centro Cardiologico Monzino SpA

    RECRUITING

    Milan, 20138, Italy

  • HUG Hospitaux Universitaires de Geneve

    RECRUITING

    Geneva, 1205, Switzerland

  • Hospital Clinic Universitario de Valladolid

    RECRUITING

    Valladolid, 47003, Spain

  • Hospital Clinic de Barcelona

    RECRUITING

    Barcelona, 08036, Spain

  • Hospital de la Princesa

    RECRUITING

    Madrid, 28006, Spain

  • Katholisches Krankenhaus "St. Johann Nepomuk"

    RECRUITING

    Erfurt, 99097, Germany

  • Klinikum der Ludwig-Maximilians-Universität München

    RECRUITING

    München, 81377, Germany

  • Klinikverbund Allgäu gGmbH

    RECRUITING

    Immenstadt and Kempten, 87509, Germany

  • Miedziowe Centrum Zdrowia S.A

    RECRUITING

    Lubin, 59-311, Poland

  • Pauls Stradins Clinical University Hospital

    RECRUITING

    Riga, 1002, Latvia

  • Semmelweis University

    RECRUITING

    Budapest, 1085, Hungary

  • University Hospital Basel

    RECRUITING

    Basel, 4031, Switzerland

  • Universitätsklinikum Halle (Saale)

    RECRUITING

    Halle, 6120, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.